An immune response that likely evolved to help fight infections appears to be the mechanism that drives human ...

But unlike the many, more common antiviral drugs that can be used to fight against viruses such as flus, protease inhibitors can also be used to help combat HIV (human immunodeficiency virus).

Dolutegravir is an HIV integrase strand transfer inhibitor ... integrase mutations to significantly impair dolutegravir antiviral activity. Dolutegravir is well tolerated with few treatment ...

They cited “exposure” laws specifically, which criminalize the transmission of or perceived exposure of someone else to HIV. Such laws were passed in the early days of the AIDS epidemic, before the ...

Unlike other antiviral HIV therapies, lenacapavir targets multiple steps of viral replication. The drug has also proved highly successful in clinical trials, as a Pre-Exposure Prophylaxis (PrEP ...

With antivirals coming off patent, and the fact that HIV medications are second only to psychiatric medications in total expense to most US correctional facilities, many more expensive fixed-dose ...

HIV Infection Statistics Underpin Market Expansion Current epidemiological data underscores the need for continued innovation and access to antiviral drugs. With approximately 39 million people ...

DALLAS, TX / ACCESSWIRE / November 19, 2024 / Adnexus Biotechnologies Inc. is pleased to announce the appointment of Dr. Hiroshi Ohrui to its Scientific Advisory Board. Dr. Ohrui is a distinguished ...

BMO Capital Markets analyst Evan Seigerman in a note to investors called Gilead’s third-quarter performance “consistent” and ...

Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...

Gilead Sciences posted robust revenue and EPS growth, exceeding expectations, and management raised full-year guidance.

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...